AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakajo, M.
Right arrow Articles by Nakajo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakajo, M.
Right arrow Articles by Nakajo, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.08.1304
AJR 2009; 192:754-760
© American Roentgen Ray Society


Original Research

Effect of Clinicopathologic Factors on Visibility of Colorectal Polyps with FDG PET

Masatoyo Nakajo1,2, Seishi Jinnouchi1, Yukie Tashiro3, Hiroshi Shirahama3, Eiichi Sato3, Chihaya Koriyama4 and Masayuki Nakajo2

1 Department of Radiology, Atsuchi Memorial Clinic PET Center, 12-1 Terukuni, Kagoshima City, 892-0841, Japan.
2 Department of Radiology, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
3 Department of Pathology, Imakiire General Hospital, Kagoshima, Japan.
4 Department of Epidemiology and Preventive Medicine, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

OBJECTIVE. The objective of our study was to clarify which clinicopathologic factors affect the FDG PET visibility of colorectal polyps.

MATERIALS AND METHODS. We used statistical methods in a retrospective examination of factors affecting the visibility of 87 colorectal polyps in 50 patients who underwent PET for cancer screening.

RESULTS. PET depicted 37% (32/87) of polyps. Univariate analysis revealed significant associations between polyp visibility and polyp size, histologic grade (p < 0.001 each), type (p = 0.004), and patient age (p = 0.049) but not sex or polyp location. The visualization rate increased with increases in polyp size (≤ 5 mm, 12%; 6–10 mm, 47%; ≥ 11 mm, 59%) and severity of dysplasia (indefinite or low-grade dysplasia, 13%; high-grade dysplasia, 67%; polyp with early carcinoma, 75%) and was higher for pedunculated polyps (59%) than for nonpedunculated polyps (27%). Multivariate analysis showed that histologic grade was the strongest factor (p < 0.001) among three independent factors (histologic grade, type, and age). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for visualization of high-grade or early carcinoma polyps to be removed were 71%, 87%, 78%, 82%, and 80%. Maximum standardized uptake values did not differ significantly between visualized polyps with indefinite or low-grade dysplasia and visualized polyps with high-grade dysplasia or early carcinoma.

CONCLUSION. Histologic grade is the strongest independent factor in FDG PET visibility of colorectal polyps. FDG PET visibility may be helpful for predicting whether a polyp should be removed or observed. FDG PET findings also may suggest the need to alter the treatment of patients with colorectal polyps.

Keywords: colon • early carcinoma • FDG • PET • polyp


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Roentgen Ray Society.